A detailed history of Schroder Investment Management Group transactions in Evolus, Inc. stock. As of the latest transaction made, Schroder Investment Management Group holds 832,798 shares of EOLS stock, worth $9.04 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
832,798
Previous 1,161,738 28.31%
Holding current value
$9.04 Million
Previous $12.2 Million 4.69%
% of portfolio
0.01%
Previous 0.02%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$9.99 - $14.91 $3.29 Million - $4.9 Million
-328,940 Reduced 28.31%
832,798 $11.7 Million
Q4 2023

Feb 13, 2024

SELL
$7.6 - $10.53 $4.49 Million - $6.22 Million
-590,857 Reduced 33.71%
1,161,738 $12.2 Million
Q3 2023

Nov 14, 2023

BUY
$7.15 - $10.2 $826,876 - $1.18 Million
115,647 Added 7.06%
1,752,595 $16 Million
Q2 2023

Aug 11, 2023

SELL
$7.23 - $10.52 $29,809 - $43,373
-4,123 Reduced 0.25%
1,636,948 $11.9 Million
Q1 2023

May 11, 2023

SELL
$7.81 - $11.05 $201,615 - $285,255
-25,815 Reduced 1.55%
1,641,071 $13.9 Million
Q4 2022

Feb 10, 2023

SELL
$6.52 - $8.95 $4,779 - $6,560
-733 Reduced 0.04%
1,666,886 $12.5 Million
Q3 2022

Nov 10, 2022

SELL
$7.76 - $13.72 $262,939 - $464,888
-33,884 Reduced 1.99%
1,667,619 $13.4 Million
Q2 2022

Aug 11, 2022

SELL
$10.22 - $13.94 $5.49 Million - $7.49 Million
-537,356 Reduced 24.0%
1,701,503 $19.7 Million
Q1 2022

May 16, 2022

SELL
$5.22 - $11.78 $409,362 - $923,811
-78,422 Reduced 3.38%
2,238,859 $24.8 Million
Q4 2021

Feb 14, 2022

BUY
$5.37 - $8.38 $3.42 Million - $5.33 Million
636,109 Added 37.84%
2,317,281 $15.1 Million
Q3 2021

Nov 12, 2021

BUY
$7.36 - $13.67 $2.37 Million - $4.4 Million
321,843 Added 23.68%
1,681,172 $12.8 Million
Q2 2021

Aug 13, 2021

BUY
$8.42 - $13.96 $3.9 Million - $6.47 Million
463,730 Added 51.78%
1,359,329 $17.2 Million
Q1 2021

May 17, 2021

SELL
$3.2 - $16.51 $1.54 Million - $7.94 Million
-480,860 Reduced 34.93%
895,599 $11.6 Million
Q4 2020

Feb 16, 2021

BUY
$2.92 - $4.84 $45,479 - $75,383
15,575 Added 1.14%
1,376,459 $4.63 Million
Q3 2020

Nov 13, 2020

BUY
$3.03 - $5.48 $695,303 - $1.26 Million
229,473 Added 20.28%
1,360,884 $5.69 Million
Q2 2020

Aug 13, 2020

BUY
$3.53 - $6.17 $311,670 - $544,761
88,292 Added 8.46%
1,131,411 $6 Million
Q1 2020

May 15, 2020

BUY
$3.53 - $12.21 $310,717 - $1.07 Million
88,022 Added 9.22%
1,043,119 $4.06 Million
Q4 2019

Feb 11, 2020

BUY
$11.58 - $17.37 $11.1 Million - $16.6 Million
955,097 New
955,097 $11.6 Million
Q1 2019

May 14, 2019

SELL
$12.43 - $28.91 $5.83 Million - $13.5 Million
-468,678 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$10.57 - $19.29 $4.95 Million - $9.04 Million
468,678 New
468,678 $5.58 Million
Q2 2018

Aug 13, 2018

SELL
$6.85 - $38.49 $3.43 Million - $19.2 Million
-500,000 Closed
0 $0
Q1 2018

May 11, 2018

BUY
$8.34 - $12.5 $4.17 Million - $6.25 Million
500,000 New
500,000 $4.52 Million

Others Institutions Holding EOLS

About Evolus, Inc.


  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $609M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.